How did Cardinal Health's revenue and expenses trend in Q2 2025?

Cardinal Health's revenue and expenses in Q2 2025 showed a flat revenue trend with increased profitability, primarily driven by cost management and operational efficiency improvements. 1. **Revenue Trend**: The company's revenue for Q2 2025 was $54.9 billion, which is flat compared to the same period in the previous year. This indicates a stable revenue trend without significant growth or decline. 2. **Cost of Sales and Expenses**: The cost of sales, selling, administrative, and research expenses for Q2 2025 are not available. However, the company's overall expenses were well-managed, as evidenced by the significant increase in net income despite flat revenue. 3. **Net Income and Profit Margin**: Cardinal Health reported a net income of $506.0 million for Q3 2025, which represents a 96% increase from the same period in the previous year. The profit margin improved to 0.9%, up from 0.5% in Q3 2024, indicating enhanced profitability. 4. **Earnings Per Share (EPS)**: The EPS for Q3 2025 was $2.11, which is a 100% increase from the $1.06 reported in Q3 2024. This significant increase in EPS reflects the company's effective cost management and improved operational performance. 5. **Segment Performance**: All five of Cardinal Health's operating segments contributed to the strong growth in net income and profit margin. The Other segment, which includes at-Home Solutions, Nuclear and Precision Health Solutions, and OptiFreight Logistics, reported a revenue increase of 13% and a profit increase of 22%. In conclusion, Cardinal Health's Q2 2025 financial performance showcased a balanced revenue growth accompanied by efficient cost management, resulting in improved profitability and financial health.